Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study
暂无分享,去创建一个
N. Tinari | A. Veronese | C. Ficorella | K. Cannita | A. Grassadonia | A. Parisi | A. Cortellini | E. Porreca | F. Zoratto | P. Vici | M. Barba | T. Gamucci | C. Natoli | M. De Tursi | P. Di Marino | Matteo Neri